ÐÂÎÅ×ÊѶ
ϲ±¨ | ½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÖÆÒ©¼¯ÍÅWP103£¨Ê¯É¼¼î¼××¢ÉäÒº£©»ñÃÀ¹úFDAÁÙ´²ÊÔÑéÔÊÐí
ÈÕÆÚ£º
2025Äê01ÔÂ21ÈÕ 10:15
ÃÀ¹ú¶«²¿Ê±¼ä2025Äê1ÔÂ16ÈÕ£¬£¬£¬ £¬ £¬£¬£¬ÃÀ¹úʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨FDA£©ÕýʽÔÊÐíÁ˱¾¹«Ë¾×ÔÖ÷Ñз¢µÄʯɼ¼î¼××¢ÉäÒº£¨Ñз¢²úÆ·´úºÅWP103£©ÖÎÁÆÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡£¡£¡£¡£¡£¡£¡£¡£¨HIE£©µÄÐÂÒ©ÁÙ´²ÊÔÑ飨IND£©ÉêÇë¡£¡£¡£¡£¡£¡£¡£¡£¸ÃÔÊÐí±ê¼Ç×ÅWP103ÐÂÒ©µÄÑз¢½øÈëÁÙ´²½×¶Î¡£¡£¡£¡£¡£¡£¡£¡£
ÕâÒâζ׎ñÄê»á¹ÙÍøµÇ¼Èë¿Ú½«ÎªÐÂÉú¶ùHIEÕâһȫÇò¼±ÐèÒ©ÎïÁÆ·¨µÄ¼²²¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬µÓÚ¨¿ªÍØÐÔÑо¿µÄ»ù´¡£¡£¡£¡£¡£¡£¡£¡£»£»£»£»£»£»£»ÔÚÈ«ÌìϹæÄ£ÄÚÊ״οª´´ÐԵؽ«Ê¯ÉÀ¼î¼×ÕâÒ»¶àÖØ»ñÒæµÄµ¨¼îõ¥Ã¸ÒÖÖƼÁÓ¦ÓÃÓÚÐÂÉú¶ùHIEÕâÒ»ÖÂËÀÖ²еÄÑÏÖضù¿Æ¼²²¡£¡£¡£¡£¡£¡£¡£¡£»£»£»£»£»£»£»Ò²±ê¼Ç׎ñÄê»á¹ÙÍøµÇ¼Èë¿Ú¶ÔÖйúÔ´´Ò©“ʯɼ¼î¼×”ÔÚÐÂÖƼÁ¡¢ÐÂ˳Ӧ֢Á¢ÒìÑз¢¼°½á¹¹È«ÇòÊг¡µÄÓÖÒ»Ö÷ÒªÀï³Ì±®¡£¡£¡£¡£¡£¡£¡£¡£
¹ØÓÚÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡£¨HIE£©
HIEÊÇÓÉÐÂÉú¶ùÄÔ×é֯ȱÑõºÍÄÔѪÁ÷Á¿ïÔÌÒýÆðµÄÒ»ÖÖÐÂÉú¶ùÄÔËðÉ˼²²¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬¶Ô·¢ÓýÖеĴóÄÔÓÐÑÏÖØÓ°Ï죬£¬£¬ £¬ £¬£¬£¬²¢¿ÉÄܵ¼ÖÂÏÔÖøµÄéæÃüÂʺͷ¢²¡ÂÊ¡£¡£¡£¡£¡£¡£¡£¡£ÔÚÃÀ¹ú£¬£¬£¬ £¬ £¬£¬£¬HIEÿÄêÓ°ÏìԼĪ²»µ½10,000ÃûÓ¤¶ù£»£»£»£»£»£»£»È«Çò¹æÄ£ÄÚ£¬£¬£¬ £¬ £¬£¬£¬Ã¿ÄêÔ¼75ÍòÓ¤¶ùî¾»¼ÖжȻòÖضÈHIE£¬£¬£¬ £¬ £¬£¬£¬µ¼ÖÂÔ¼400,000ÃûÓ¤¶ù»¼ÓÐÉñ¾·¢ÓýÕÏ°¡£¡£¡£¡£¡£¡£¡£¡£
ÏÖÔÚ£¬£¬£¬ £¬ £¬£¬£¬ÃÀ¹úÉÐÎÞ»ñÅúÒ©ÎïÓÃÓÚÖÎÁÆÐÂÉú¶ùHIE¡£¡£¡£¡£¡£¡£¡£¡£Å¹ú¼ÒÕë¶ÔÐÂÉú¶ùÖÐÖضÈHIEµÄ±ê×¼¸ÉÔ¤ÒªÁìÖ»ÄÜÊÇÖÎÁÆÐÔµÍΣ¨TH£©£¬£¬£¬ £¬ £¬£¬£¬µ«½ÓÊÜ TH ÖÎÁƵÄÖÐÖØHIEÐÂÉú¶ùÈÔÈ»»áÂÄÀúɱ¾øÐԵIJ¢·¢Ö¢£º48%µÄéæÃü»òÖжÈ/ÖضȲм²¡£¡£¡£¡£¡£¡£¡£¡£Òò´Ë£¬£¬£¬ £¬ £¬£¬£¬µ±ÐÂÉú¶ù±¬·¢HIEʱ£¬£¬£¬ £¬ £¬£¬£¬ºÜÊǼ±ÐèÇå¾²ÓÐÓõÄÖÎÁÆ£¬£¬£¬ £¬ £¬£¬£¬²¢ÇÒ¹ØÓÚ²»ÊÊÓÃÓÚTHµÄÇáÖ¢HIE²¡ÀýÒ²ÐèÒªÓÐÓõÄÒ©ÎïÁÆ·¨¡£¡£¡£¡£¡£¡£¡£¡£
¹ØÓÚWP103Õë¶ÔHIEµÄINDÉêÇë»ñµÃÃÀ¹úFDAÔÊÐí
¹«Ë¾±¾´ÎµÄINDÅú×¼£¬£¬£¬ £¬ £¬£¬£¬ÊÇÒÔ¹«Ë¾Ñз¢ÓëÊÖÒÕÍŶӿªÕ¹µÄ¸ßÖÊÁ¿¡¢ÇкÏFDAÓëICHÒªÇóµÄÁÙ´²Ç°Ò©Ñ§£¨ÖÊÁÏÒ©¡¢ÖƼÁ£©ºÍÒ©Àí¶¾ÀíÑо¿Îª»ù´¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬ÍŽáÒÑÓеÄÈËÓÃÂÄÀúÓëÇå¾²ÐÔÊý¾Ý£¬£¬£¬ £¬ £¬£¬£¬FDA·¢³öStudy May Proceed£¨ÁÙ´²Ñо¿¿ÉÒÔÆô¶¯£©Í¨Öª¡£¡£¡£¡£¡£¡£¡£¡£
±¾¹«Ë¾µÄʯɼ¼î¼××¢ÉäÒº£¬£¬£¬ £¬ £¬£¬£¬ÓÐÍûΪ»¼ÕßÌṩÁÆЧÏÔÖø¡¢Çå¾²ÐԺõÄÖÎÁÆÑ¡Ôñ¡£¡£¡£¡£¡£¡£¡£¡£WP103Ϊʯɼ¼î¼××¢ÉäÓÃСÈÝÁ¿Ë®Õ룬£¬£¬ £¬ £¬£¬£¬×¨Îª±¬·¢Î§²úÆÚȱÑõȱѪµÄ»¼¶ùÉè¼Æ¡£¡£¡£¡£¡£¡£¡£¡£Ê¯É¼¼î¼××÷ΪһÖָ߻îÐÔ¡¢¸ßÑ¡ÔñÐԵĵ¨¼îõ¥Ã¸ÒÖÖƼÁ£¬£¬£¬ £¬ £¬£¬£¬Í¬Ê±¾ßÓÐÃâÒßµ÷Àí¡¢¿¹Ñõ»¯Ó¦¼¤¡¢Éñ¾Ôª±£»£»£»£»£»£»£»¤µÈ×÷Ó㬣¬£¬ £¬ £¬£¬£¬ÇÒÄÔÄÚÉúÎïʹÓöÈÓÅÒì¡£¡£¡£¡£¡£¡£¡£¡£
ÁÙ´²Ç°Ñо¿Åú×¢£¬£¬£¬ £¬ £¬£¬£¬ÔÚneonatal HIEÄ£×ÓÖУ¬£¬£¬ £¬ £¬£¬£¬Ê¯É¼¼î¼××¢ÉäÒº²»µ«Äܹ»¼ÁÁ¿ÒÀÀµÐԵĸÄÉÆÈÏÖª¡¢Ó°Ïó¡¢Ô˶¯ÄÜÁ¦£¬£¬£¬ £¬ £¬£¬£¬²¢ÇÒÏÔÖø½µµÍÁ˹£ËÀÃæ»ý¡¢ÄÔËðÉË£¬£¬£¬ £¬ £¬£¬£¬Í¬Ê±£¬£¬£¬ £¬ £¬£¬£¬Ò²ÏÔÖø½µµÍȱÑõȱѪÔì³ÉµÄÉñ¾ÔªéæÃü¡£¡£¡£¡£¡£¡£¡£¡£
¹ØÓÚ½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÁ¢ÒìÒ©»ñÈ«Çò¹æÄ£²»¿É¶àµÃFDAË«È϶¨µÄÓÅÊÆ
¹«Ë¾ÓÚ2024Äê4ÔÂβ»ñµÃFDAÊÚÓèµÄʯɼ¼î¼×ÖÎÁÆÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡£¡£¡£¡£¡£¡£¡£¡£¨HIE£©µÄÓÐÊý¶ù¿Æ¼²²¡ÓÃÒ©È϶¨(rare pediatric disease designation£¬£¬£¬ £¬ £¬£¬£¬RPDD)£¬£¬£¬ £¬ £¬£¬£¬ÓÖÓÚ2024Äê5ÔÂβ»ñµÃFDAÊÚÓèµÄÖÎÁÆÐÂÉú¶ùHIEµÄ¹Â¶ùÒ©È϶¨(orphan drug designation, ODD)¡£¡£¡£¡£¡£¡£¡£¡£×÷ΪȫÇò¹æÄ£ÄÚ²»¿É¶àµÃµÄ»ñµÃFDAË«È϶¨µÄÒ©Æ·£¬£¬£¬ £¬ £¬£¬£¬RPDDºÍODDÈ·±£Á˸ßÁÙ´²¼ÛֵDZÁ¦µÄʯɼ¼î¼×µÄ¸ßÉÌÒµ¼ÛÖµ£¬£¬£¬ £¬ £¬£¬£¬°üÀ¨£º´ÓÒ©Æ·»ñÅú×îÏȵÄ7ÄêµÄÊг¡×¨ÓªÈ¨(market exclusivity)¡¢ÐÂÒ©ÉêÇë(NDA)µÄÓÅÏÈÉóÆÀÉóÅú¡¢ÐÂÒ©NDA×¢²áÓöȵÄÃâÈ¥(Ô¼3000ÍòÈËÃñ±Ò)£¬£¬£¬ £¬ £¬£¬£¬ÒÔ¼°ÔÚÁÙ´²¿ª·¢Àú³ÌÖиü¶àµÄFDAµÄÖ¸µ¼ÓëÖ§³Ö£¬£¬£¬ £¬ £¬£¬£¬ÅäºÏÔö½øHIEÕâÒ»ÑÏÖغÍΣ¼°ÉúÃüµÄ¶ù¿ÆÓÐÊý¼²²¡Ò©ÎïµÄÑз¢¡£¡£¡£¡£¡£¡£¡£¡£
±¾´ÎÉ걨µÄÐÂÉú¶ùHIE˳Ӧ֢£¬£¬£¬ £¬ £¬£¬£¬ÕâÒ»µ¼ÖÂÓ¤¶ùéæÃü¡¢ÖØ´ó²Ð¼²µÄÑÏÖؼ²²¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬ÃÀ¹úÉÐÎÞ»ñÅúµÄÖÎÁÆÒ©Î£¬£¬ £¬ £¬£¬£¬±£´æÑÏÖصÄδ֪×ãÁÙ´²ÐèÇ󡣡£¡£¡£¡£¡£¡£¡£¹«Ë¾ÒóÇÐÏ£Íûʯɼ¼î¼×µÄÁÆЧºÍÇå¾²ÐÔÄܹ»¿ìËÙÔÚÁÙ´²ÉÏ»ñµÃÑéÖ¤£¬£¬£¬ £¬ £¬£¬£¬´Ó¶øÌî²¹ÐÂÉú¶ùHIEÖÎÁƵÄÈ«ÇòÁÙ´²ÐèÇ󡣡£¡£¡£¡£¡£¡£¡£ÆÚ´ý¾ÍÁÙ´²ÊÔÑéµÄÉêÇë»ñµÃFDAµÄÆð¾¢·´À¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬ÍƽøWP103µÄ¿ìËÙ¡¢¸ßÖÊÁ¿µÄÁÙ´²¿ª·¢£¬£¬£¬ £¬ £¬£¬£¬ÔçÈÕ½«¸üºÃµÄÁÙ´²Ñ¡Ôñ´ø¸øÈ«ÇòǧÍòÍòÍòÊÜHIEÍþвµÄ»¼¶ùºÍ¼ÒÍ¥¡£¡£¡£¡£¡£¡£¡£¡£
½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÖÆÒ©½«Ò»Á¬Íƽø¸ÃÑз¢ÏîÄ¿£¬£¬£¬ £¬ £¬£¬£¬Æð¾¢×öºÃ¸ÃÏîÄ¿ÁÙ´²Ñо¿µÄ×¼±¸Ó뿪չ£¬£¬£¬ £¬ £¬£¬£¬Á¦ÕùʵÏÖWP103µÄÔçÈÕÉÏÊУ¬£¬£¬ £¬ £¬£¬£¬½«ÕâÒ»ÓÃÒ©ÖØ´óDZÔÚÁÙ´²ÓÅÊƵÄÁÆ·¨´ø¸øÈ«Çò¼±ÐèÇå¾²ÐԺá¢ÁÆЧÃ÷È·µÄÁÆ·¨µÄ»¼¶ùºÍËûÃǵļÒÍ¥¡£¡£¡£¡£¡£¡£¡£¡£
¹ØÓÚ½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÑз¢
½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÏÖÔÚ½¨ÓÐÔ¼120È˵ÄÑз¢ÍŶӣ¬£¬£¬ £¬ £¬£¬£¬Äܹ»¿ªÕ¹È«¼ÛÖµÁ´µÄÒ©Æ·Ñз¢ÊÂÇ飬£¬£¬ £¬ £¬£¬£¬´ÓÔçÆÚ·¢Ã÷µÄÉè¼Æ¡¢»¯Ñ§¡¢ÉúÎïѧ£¬£¬£¬ £¬ £¬£¬£¬µ½ IND-enablingµÄҩѧÓëÒ©Àí¶¾ÀíÑо¿£¬£¬£¬ £¬ £¬£¬£¬ÒÔ¼°ÁÙ´²¿ª·¢µÄÍýÏëÓëÔËÓª¡£¡£¡£¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬ £¬ £¬£¬£¬¹«Ë¾½¨ÓÐԺʿÊÂÇéÕ¾¡¢²©Ê¿ºóÊÂÇéÕ¾¡¢Ê¡¼¶ÊÖÒÕ¡¢Ñз¢ÖÐÐĵȶà¸ö¸ß¶Ëƽ̨£¬£¬£¬ £¬ £¬£¬£¬ÎªÒ©Æ·Ñз¢ÌṩÐÛºñµÄÈ˲ÅÓëר¼ÒÖ§³Ö¡£¡£¡£¡£¡£¡£¡£¡£
¹«Ë¾Ñз¢¹ÜÏ߸»ºñ£¬£¬£¬ £¬ £¬£¬£¬ÐγÉÁËÁ¢ÒìÒ©Ñз¢¡¢·ÂÖÆÒ©Ñз¢¡¢ÖÊÁÏÒ©Ñз¢¡¢ÖÐÒ©Ñз¢ÆëÍ·²¢½øµÄ´óÑз¢ÏµÍ³ÓëÃûÌᣡ£¡£¡£¡£¡£¡£¡£ÆäÖУ¬£¬£¬ £¬ £¬£¬£¬Á¢ÒìÒ©Ñз¢¾Û½¹£¨ÖØ´ó£©Éñ¾ÏµÍ³¼²²¡¡¢´úл¡¢×ÔÌåÃâÒß¡¢ÓÐÊý²¡µÈËÄ´óÁìÓò£¬£¬£¬ £¬ £¬£¬£¬¼½Íû³ä·ÖÑéÕ¹¹«Ë¾¶àÄêµÄÊý¾Ý»ýÀÛ£¬£¬£¬ £¬ £¬£¬£¬Îª»¼Õß´øÀ´ÁÙ´²Ø½ÐèµÄÁ¢ÒìÁÆ·¨¡£¡£¡£¡£¡£¡£¡£¡£
»ùÓÚ¶àÄêµÄÊý¾Ý»ýÀۺͶԴó×ÚÊý¾ÝµÄ¶´²ì£¬£¬£¬ £¬ £¬£¬£¬½ñÄê»á¹ÙÍøµÇ¼Èë¿ÚÁ¢ÒìÒ©ÍŶÓÔÚÈ«Çò¹æÄ£ÄÚÊ×´´»ñµÃʯɼ¼î¼×ÖÎÁÆÐÂÉú¶ùHIEµÄODDºÍRPDDµÄÈ϶¨£¬£¬£¬ £¬ £¬£¬£¬²¢ÔÚ¶Ìʱ¼äÄÚÍê³É¸ßÖÊÁ¿µÄÁÙ´²Ç°ÊÂÇ飬£¬£¬ £¬ £¬£¬£¬»ñµÃFDAµÄINDÁÙ´²Åú¼þ£¬£¬£¬ £¬ £¬£¬£¬³ä·ÖÏÔʾÁ˳¬¸ßµÄÐÂÒ©Ñз¢ÄÜÁ¦£¬£¬£¬ £¬ £¬£¬£¬ÒÔ¼°¼ÓËÙÍƽø½â¾ö»¼ÕßؽÐèµÄרҵ¾«Éñ¡£¡£¡£¡£¡£¡£¡£¡£
Ïà¹ØÍƼö
2021/02/07
2021/02/07
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ